7283062
Descripción
Fichas por Kate Parvey, actualizado hace más de 1 año
|
Creado por Kate Parvey
hace alrededor de 8 años
|
|
| Pregunta | Respuesta |
| Duramorph/ Morphine Route & Dose | SC, IV, IM, Epidural, Intrathecal INITIAL DOSE: 2 mg to 10 mg/70 kg weight. Epidural Initial injection of 5 mg in the lumbar region for pain relief for up to 24 hours. If NOT adequate pain relief within one hour, incremental doses of 1 to 2 mg at intervals sufficient to assess effectiveness may be given. No more than 10 mg/24 hour should be administered. |
| Duramorph/ Morphine Class & Action | NARCOTIC ANALGESIC Given in the Epidural Systemic narcotic analgesic for extended pain relief w/o loss of motor, sensory or sympathetic function. Preferred opiate to use while breastfeeding due to poor oral bioavailability. Also used to treat Drug Withdrawal Syndrome in Newborn Infant. |
| Duramorph/ Morphine Side Effects & LR/PR | SE: Sedation, constipation LR/PR: L3/C Preferred opiate while breastfeeding due to poor oral bioavailability. |
| Naloxone/ Narcan Route & Dose | SC or IM 0.4 mg SC/IM Q2-3min PRN |
| Naloxone / Narcan Class & Action | NARCOTIC ANTAGONIST Opioid overdose Occupies opiate receptor sites; displaces opioids already at opiate receptor sites |
| Naloxone / Narcan Side Effects & LR/PR | SE: Tachycardia, HTN, hypotension, nausea, vomiting, tremor, withdrawal symptoms, diaphoresis, pulmonary edema, dyspnea LR/PR: L3/C AAP: Should not be administered to infants of narcotic-dependent mothers; rapid withdrawal symptoms. |
| Fentanyl (discontinued) / Sublimaze/ Duragesic Route & Dose | IV 100 mg (2-20 ug/kg) IV: Administer by slow IV push over 3-5 minutes or by continuous infusion; larger bolus doses (>5 mcg/kg) should be given slow IV push over 5-10 minutes. Muscular rigidity may occur with rapid IV administration. |
| Fentanyl (discontinued) / Sublimaze/ Duragesic Class & Action | POTENT NARCOTIC ANALGESIC ;OPIOID For Labor Pain Fentanyl binds with stereospecific receptors at many sites within the CNS, increases pain threshold, alters pain reception, inhibits ascending pain pathways. |
| Fentanyl (discontinued) / Sublimaze/ Duragesic Side Effects & LR/PR | SE: Apnea, respiratory depression, muscle rigidity, hypotension, bradycardia Physical and psychological dependence with prolonged use. LR/PR: L2/C Note: neonates who receive a total fentanyl dose >1.6mg/kg or continuous infusion duration >5 days are more likely to develop narcotic withdrawal symptoms. |
| Ketoralac/ Toradol (discontinued) / Acular Route & Dose | PO, IM, IV PO: 10 mg Q6 hours IV/IM: 30 mg Q6h; Max: 120 mg/day |
| Ketoralac/ Toradol (discontinued) / Acular Class & Action | NSAID used for its analgesic activity Postpartum Pain Blocks Cyclooxygenase (COX) enzymes that are needed to produce prostaglandin. |
| Ketoralac/ Toradol (discontinued) / Acular Side Effects & LR/PR | SE: Headache, nausea, abdominal pain, dyspepsia, dizziness, somnolence, constipation, diarrhea, edema, rash LR/PR: L2/C; D in 3rd trimester |
| Nitrous Oxide / Nitronox Route & Dose | Intermittent inhalation via face mask 50% oxygen and 50% N20 Self-administered by the mother ONLY. |
| Nitrous Oxide / Nitronox Class & Action | ANALGESIA For Labor Pain Endogenous opioid release occurs with associated analgesia, and N-methyl-Daspartate receptor inhibition reduces hyperalgesia. N2O, when used at concentrations of < 50% and as a sole agent, is defined by ASA criteria as analgesia minimal sedation. High concentrations for prolonged periods may be harmful. |
| Nitrous Oxide / Nitronox Side Effects & LR/PR | SE: Nausea and vertigo, euphoria LRPR: L3/C |
| Nubain (discontinued) / Nalbuphine Route & Dose | IM/ IV/SC Non-opioidtolerant patients: 10-20 mg/70kg Q3-6hr PRN; *not to exceed 20 mg As Anesthesia Supplement 0.3-3 mg/kg IV over 10-15 minutes, then 0.25-0.5 mg/kg PRN Opioid-dependent patients: Administer ¼ dose, and observe for withdrawal signs Not to exceed 160 mg/day |
| Nubain (discontinued) / Nalbuphine Class & Action | POTENT NARCOTIC ANALGESIC For Labor Pain Opioid agonist/antagonist; inhibits ascending pain pathways Both an antagonist and agonist of opiate receptors and should not be mixed with other opiates: interference with analgesia. |
| Nubain (discontinued) / Nalbuphine Side Effects & LR/ PR | SE: Hypotension, sedation, withdrawal syndrome, respiratory depression in mother and baby LR/PR: L2/ B |
| Bupivicaine On-Q Pump Route & Dose | Via Catheter at wound site Dose rate variable : 1-7 mL/hr and 2-14 mL/hr A portable device ON-Q pump continuously infuses the local anesthetic through 2 small catheters inserted at wound site. *To be given only by or under the direct supervision of a doctor. |
| Bupivicaine On-Q Pump Class & Action | LOCAL ANESTHETIC (caine drug) prevents pain by blocking signals at nerve endings |
| Bupivicaine On-Q Pump Side Effects & LR/PR | SE: Sedation, bradycardia, respiratory depression. LR/PR: L2/C |
| Ropivacaine On-Q Pump Route & Dose | Via Catheters at wound site Dose Rate Variable: 1-7 mL/hr and 2-14 mL/ hr A portable device ON-Q pump continuously infuses the local anesthetic through 2 small catheters inserted at the wound site. |
| Ropivacaine On-Q Pump Class & Action | Amide LOCAL ANESTHETIC Blocks the generation and conduction of nerve 8 impulses, by increasing the threshold for electrical excitation in the nerve |
| Ropivacaine On-Q Pump Side Effects & LR/PR | SE: Sedation, bradycardia, respiratory depression. LR/PR: L2/B |
| Stadol (discontinued) / Butorphanol Route & Dose | IM / IV Initial dose: 1 or 2 mg once. May be repeated in 4 hours if necessary |
| Stadol (discontinued) / Butorphanol Class & Action | Potent NARCOTIC ANALGESIC; OPIOID agonist/antagonist For Labor Pain Inhibits ascending pain pathways, thus altering response to pain Alternative analgesia should be used if delivery is expected to occur within 4 hours. |
| Stadol (discontinued) / Butorphanol Side Effects & LR/PR | SE: Sedation, respiratory depression LR/PR: L2/C |
¿Quieres crear tus propias Fichas gratiscon GoConqr? Más información.